Zidovudine
NDC 31722-509, Zidovudine, tablet, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-509
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090092
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-509 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZIDOVUDINE300 mg/1
Pharmacologic classes
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-509-60 | 31722050960 | 12 BOTTLE in 1 CASE (31722-509-60) / 60 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ca9f0c57-fc8b-4da4-a987-0fc52b7fd4f4NADAC price for package 31722050960
GET /v1/drugs/nadac/31722050960
Use it
Look up 31722-509 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-509 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-509. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.